A monoallelic SEC23A variant E599K associated with cranio-lenticulo-sutural dysplasia.

SEC23A coat protein complex II cranio-lenticulo-sutural dysplasia whole genome sequencing

Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
01 2022
Historique:
revised: 25 08 2021
received: 28 06 2021
accepted: 26 08 2021
pubmed: 29 9 2021
medline: 8 4 2022
entrez: 28 9 2021
Statut: ppublish

Résumé

Cranio-lenticulo-sutural dysplasia (CLSD; MIM 607812) is a rare or underdiagnosed condition, as only two families have been reported. The original family (Boyadjiev et al., Human Genetics, 2003, 113, 1-9 and Boyadjiev et al., Nature Genetics, 2006, 38, 1192-1197) showed recessive inheritance of the condition with a biallelic SEC23A missense variant in affected individuals. In contrast, another child with sporadic CLSD had a monoallelic SEC23A variant inherited from the reportedly unaffected father (Boyadjiev et al., Clinical Genetics, 2011, 80, 169-176), raising questions on possible digenism. Here, we report a 2-month-old boy seen because of large fontanels with wide cranial sutures, a large forehead, hypertelorism, a thin nose, a high arched palate, and micrognathia. His mother was clinically unremarkable, while his father had a history of large fontanels in infancy who had closed only around age 10 years; he also had a large forehead, hypertelorism, a thin, beaked nose and was operated for bilateral glaucoma with exfoliation of the lens capsule. Trio genome sequencing and familial segregation revealed a monoallelic c.1795G > A transition in SEC23A that was de novo in the father and transmitted to the proband. The variant predicts a nonconservative substitution (p.E599K) in an ultra-conserved residue that is seen in 3D models of yeast SEC23 to be involved in direct binding between SEC23 and SAR1 subunits of the coat protein complex II coat. This observation confirms the link between SEC23A variants and CLSD but suggests that in addition to the recessive inheritance described in the original family, SEC23A variants may result in dominant inheritance of CLSD, possibly by a dominant-negative disruptive effect on the SEC23 multimer.

Identifiants

pubmed: 34580982
doi: 10.1002/ajmg.a.62506
pmc: PMC9291540
doi:

Substances chimiques

SEC23A protein, human 0
Vesicular Transport Proteins 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

319-325

Informations de copyright

© 2021 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Hum Mutat. 2009 Sep;30(9):1292-8
pubmed: 19621418
Hum Mutat. 2018 Jan;39(1):61-68
pubmed: 28967166
Acta Paediatr Suppl. 2006 Apr;450:76-85
pubmed: 16817681
Biochim Biophys Acta. 2005 Jul 10;1744(3):293-303
pubmed: 15979503
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7748-E7757
pubmed: 30065114
Science. 1993 Mar 5;259(5100):1466-8
pubmed: 8451644
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Nat Genet. 2006 Oct;38(10):1192-7
pubmed: 16980979
Gigascience. 2020 Dec 21;9(12):
pubmed: 33347570
Hum Genet. 2003 Jul;113(1):1-9
pubmed: 12677423
Histochem Cell Biol. 2008 Feb;129(2):129-51
pubmed: 18060556
Nucleic Acids Res. 2009 Jan;37(Database issue):D412-6
pubmed: 18940858
Dev Cell. 2007 Nov;13(5):623-634
pubmed: 17981132
Clin Genet. 2011 Aug;80(2):169-76
pubmed: 21039434
Nat Cell Biol. 2001 Jun;3(6):531-7
pubmed: 11389436
Bioinformatics. 2021 May 23;37(8):1171-1173
pubmed: 32926138
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Am J Med Genet A. 2022 Jan;188(1):319-325
pubmed: 34580982
Acta Crystallogr D Biol Crystallogr. 2002 Jun;58(Pt 6 No 1):899-907
pubmed: 12037327
Nat Commun. 2017 Jan 24;8:14061
pubmed: 28117401
Nucleic Acids Res. 2021 Jul 2;49(W1):W21-W28
pubmed: 34023905
EMBO J. 2008 Nov 5;27(21):2918-28
pubmed: 18843296
Nature. 2002 Sep 19;419(6904):271-7
pubmed: 12239560

Auteurs

Katarina Cisarova (K)

Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Livia Garavelli (L)

Clinical Genetics Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Stefano Giuseppe Caraffi (SG)

Clinical Genetics Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Francesca Peluso (F)

Clinical Genetics Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Lara Valeri (L)

Clinical Genetics Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Giancarlo Gargano (G)

Neonatal Intensive Care Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Sara Gavioli (S)

Neonatal Intensive Care Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Gabriele Trimarchi (G)

Clinical Genetics Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Alberto Neri (A)

Ophthalmology Unit, Department of Surgery, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Belinda Campos-Xavier (B)

Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Andrea Superti-Furga (A)

Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH